Elevated liver enzymes, ferritin, CRP, D-dimer, and age are predictive markers of outcomes among Covid-19 African Americans and Hispanic patients
暂无分享,去创建一个
H. Ashktorab | H. Brim | A. Laiyemo | G. Oskrochi | F. Aduli | A. Pizuorno
[1] J. Tanne. Covid-19: US cases surge but vaccine distribution is slow , 2021, BMJ.
[2] J. Rodríguez-Baño,et al. LIVER MANIFESTATIONS IN COVID-19 AND THE INFLUENCE OF PRE-EXISTING LIVER DISEASE IN THE COURSE OF THE INFECTION. , 2021, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.
[3] Madhavan Krishnaswamy,et al. Post COVID-19 sequelae: venous thromboembolism complicated by lower GI bleed , 2021, BMJ Case Reports.
[4] J. Carethers. Insights into disparities observed with COVID‐19 , 2020, Journal of internal medicine.
[5] F. Michard,et al. Critically ill patients with COVID-19: are they hemodynamically unstable and do we know why? , 2020, Intensive Care Medicine.
[6] Prateek Sharma,et al. Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019 , 2020, JAMA network open.
[7] H. Ashktorab,et al. Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations , 2016, Digestive Diseases and Sciences.